{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T16:16:40Z","timestamp":1781021800410,"version":"3.54.1"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","internationaljournalofcardiology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.ijcard.2021.07.018","type":"journal-article","created":{"date-parts":[[2021,7,14]],"date-time":"2021-07-14T04:35:17Z","timestamp":1626237317000},"page":"1-8","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Medical management of anginal symptoms in women with stable angina pectoris: A systematic review of randomised controlled trials"],"prefix":"10.1016","volume":"341","author":[{"given":"Carolyn M.","family":"Webb","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Collins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.ijcard.2021.07.018_bb0005","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1093\/eurheartj\/ehz425","article-title":"2019 ESC guidelines for the diagnosis and management of chronic coronary syndromes","volume":"41","author":"Knuuti","year":"2020","journal-title":"Eur. Heart J."},{"issue":"18","key":"10.1016\/j.ijcard.2021.07.018_bb0010","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1093\/eurheartj\/ehz024","article-title":"Should NICE guidelines be universally accepted for the evaluation of stable coronary disease? A debate","volume":"40","author":"Hecht","year":"2019","journal-title":"Eur. Heart J."},{"issue":"10","key":"10.1016\/j.ijcard.2021.07.018_bb0015","doi-asserted-by":"crossref","first-page":"e56","DOI":"10.1161\/CIR.0000000000000659","article-title":"Heart disease and stroke statistics-2019 update: a report from the American Heart Association","volume":"139","author":"Benjamin","year":"2019","journal-title":"Circulation."},{"key":"10.1016\/j.ijcard.2021.07.018_bb0020","author":"Health Survey for England"},{"issue":"12","key":"10.1016\/j.ijcard.2021.07.018_bb0025","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1161\/CIRCULATIONAHA.107.720953","article-title":"Prevalence of angina in women versus men: a systematic review and meta-analysis of international variations across 31 countries","volume":"117","author":"Hemingway","year":"2008","journal-title":"Circulation."},{"issue":"12","key":"10.1016\/j.ijcard.2021.07.018_bb0030","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1001\/jama.2010.1322","article-title":"Comparative determinants of 4-year cardiovascular event rates in stable outpatients at risk of or with atherothrombosis","volume":"304","author":"Bhatt","year":"2010","journal-title":"JAMA."},{"issue":"15","key":"10.1016\/j.ijcard.2021.07.018_bb0035","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1056\/NEJMoa1915922","article-title":"Initial invasive or conservative strategy for stable coronary disease","volume":"382","author":"Maron","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.ijcard.2021.07.018_bb0040","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.jcmg.2011.03.007","article-title":"Ranolazine improves angina in women with evidence of myocardial ischemia but no obstructive coronary artery disease","volume":"4","author":"Mehta","year":"2011","journal-title":"JACC Cardiovasc. Imaging"},{"issue":"7","key":"10.1016\/j.ijcard.2021.07.018_bb0045","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Med."},{"key":"10.1016\/j.ijcard.2021.07.018_bb0050","series-title":"Cochrane Handbook for Systematic Reviews of Interventions Version 6.0 (Updated July 2019)","author":"Higgins","year":"2019"},{"issue":"3","key":"10.1016\/j.ijcard.2021.07.018_bb0055","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/0002-9149(66)90056-7","article-title":"The prophylactic value of propranolol in angina pectoris","volume":"18","author":"Rabkin","year":"1966","journal-title":"Am. J. Cardiol."},{"issue":"5","key":"10.1016\/j.ijcard.2021.07.018_bb0060","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1097\/00000441-196605000-00008","article-title":"Double blind evaluation of orally administered iproveratril in patients with angina pectoris","volume":"251","author":"Neumann","year":"1966","journal-title":"Am J Med Sci"},{"issue":"19","key":"10.1016\/j.ijcard.2021.07.018_bb0065","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1093\/eurheartj\/ehv647","article-title":"A randomized, placebo-controlled trial of late Na current inhibition (ranolazine) in coronary microvascular dysfunction (CMD): impact on angina and myocardial perfusion reserve","volume":"37","author":"Bairey Merz","year":"2016","journal-title":"Eur. Heart J."},{"issue":"1","key":"10.1016\/j.ijcard.2021.07.018_bb0070","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1161\/CIRCULATIONAHA.115.019768","article-title":"Effects of ranolazine on angina and quality of life after percutaneous coronary intervention with incomplete revascularization: results from the ranolazine for incomplete vessel revascularization (RIVER-PCI) trial","volume":"133","author":"Alexander","year":"2016","journal-title":"Circulation."},{"issue":"20","key":"10.1016\/j.ijcard.2021.07.018_bb0075","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1016\/j.jacc.2013.02.011","article-title":"Evaluation of ranolazine in patients with type 2 diabetes mellitus and chronic stable angina: results from the TERISA randomized clinical trial (type 2 diabetes evaluation of Ranolazine in subjects with chronic stable angina)","volume":"61","author":"Kosiborod","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"issue":"18","key":"10.1016\/j.ijcard.2021.07.018_bb0080","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1016\/j.jacc.2018.02.070","article-title":"Participation of women in clinical trials supporting FDA approval of cardiovascular drugs","volume":"71","author":"Scott","year":"2018","journal-title":"J. Am. Coll. Cardiol."},{"issue":"7","key":"10.1016\/j.ijcard.2021.07.018_bb0085","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1161\/CIRCULATIONAHA.119.043594","article-title":"Women\u2019s participation in cardiovascular clinical trials from 2010 to 2017","volume":"141","author":"Jin","year":"2020","journal-title":"Circulation."},{"issue":"4","key":"10.1016\/j.ijcard.2021.07.018_bb0090","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1080\/13697137.2016.1198574","article-title":"Cardiovascular risk assessment in women - an update","volume":"19","author":"Collins","year":"2016","journal-title":"Climacteric."},{"issue":"3","key":"10.1016\/j.ijcard.2021.07.018_bb0095","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1089\/jwh.2010.2469","article-title":"Inclusion, analysis, and reporting of sex and race\/ethnicity in clinical trials: have we made progress?","volume":"20","author":"Geller","year":"2011","journal-title":"J. Women\u2019s Health (Larchmt)"},{"issue":"1","key":"10.1016\/j.ijcard.2021.07.018_bb0100","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/HCR.0b013e31819276cb","article-title":"Examining the challenges of recruiting women into a cardiac rehabilitation clinical trial","volume":"29","author":"Beckie","year":"2009","journal-title":"J. Cardiopulm. Rehabil. Prev."},{"issue":"1","key":"10.1016\/j.ijcard.2021.07.018_bb0105","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1177\/014107680710000102","article-title":"Gender bias in research: how does it affect evidence based medicine?","volume":"100","author":"Holdcroft","year":"2007","journal-title":"J. R. Soc. Med."},{"issue":"9","key":"10.1016\/j.ijcard.2021.07.018_bb0110","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1001\/archinte.167.9.905","article-title":"Sex differences in perceived risks, distrust, and willingness to participate in clinical trials: a randomized study of cardiovascular prevention trials","volume":"167","author":"Ding","year":"2007","journal-title":"Arch. Intern. Med."},{"issue":"4","key":"10.1016\/j.ijcard.2021.07.018_bb0115","doi-asserted-by":"crossref","first-page":"613","DOI":"10.2105\/AJPH.92.4.613","article-title":"Effectiveness of media strategies to increase enrollment and diversity in the women\u2019s health registry","volume":"92","author":"Rogers","year":"2002","journal-title":"Am. J. Public Health"},{"key":"10.1016\/j.ijcard.2021.07.018_bb0120","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1186\/1471-2458-14-1156","article-title":"Impact of gender on the decision to participate in a clinical trial: a cross-sectional study","volume":"14","author":"Lobato","year":"2014","journal-title":"BMC Public Health"},{"issue":"2","key":"10.1016\/j.ijcard.2021.07.018_bb0125","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1177\/0963721411429452","article-title":"Both risk and reward are processed differently in decisions made under stress","volume":"21","author":"Mather","year":"2012","journal-title":"Curr. Dir. Psychol. Sci."},{"issue":"3","key":"10.1016\/j.ijcard.2021.07.018_bb0130","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1089\/jwh.2017.6458","article-title":"A multicenter investigation of factors influencing women\u2019s participation in clinical trials","volume":"27","author":"Myles","year":"2018","journal-title":"J. Women\u2019s Health (Larchmt)"},{"issue":"3","key":"10.1016\/j.ijcard.2021.07.018_bb0135","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1161\/ATVBAHA.108.179796","article-title":"Status of women in cardiovascular clinical trials","volume":"29","author":"Kim","year":"2009","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.ijcard.2021.07.018_bb0140","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.ahj.2017.03.007","article-title":"The assessment of the watchman device in patients unsuitable for oral anticoagulation (ASAP-TOO) trial","volume":"189","author":"Holmes","year":"2017","journal-title":"Am. Heart J."},{"issue":"7","key":"10.1016\/j.ijcard.2021.07.018_bb0145","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1001\/jamacardio.2020.0822","article-title":"Association of sex with severity of coronary artery disease, ischemia, and symptom burden in patients with moderate or severe ischemia: secondary analysis of the ISCHEMIA randomized clinical trial","volume":"5","author":"Reynolds","year":"2020","journal-title":"JAMA Cardiol."},{"issue":"24","key":"10.1016\/j.ijcard.2021.07.018_bb0150","doi-asserted-by":"crossref","first-page":"e44","DOI":"10.1016\/j.jacc.2012.07.013","volume":"60","author":"Fihn","year":"2012","journal-title":"J. Am. Coll. Cardiol."},{"issue":"23 Pt A","key":"10.1016\/j.ijcard.2021.07.018_bb0155","doi-asserted-by":"crossref","first-page":"2841","DOI":"10.1016\/j.jacc.2018.09.006","article-title":"Stratified medical therapy using invasive coronary function testing in Angina: the CorMicA trial","volume":"72","author":"Ford","year":"2018","journal-title":"J. Am. Coll. Cardiol."},{"issue":"10115","key":"10.1016\/j.ijcard.2021.07.018_bb0160","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0140-6736(17)32714-9","article-title":"Percutaneous coronary intervention in stable angina (ORBITA): a double-blind, randomised controlled trial","volume":"391","author":"Al-Lamee","year":"2018","journal-title":"Lancet."},{"issue":"16","key":"10.1016\/j.ijcard.2021.07.018_bb0165","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1001\/archinternmed.2009.295","article-title":"The prevalence of weekly angina among patients with chronic stable angina in primary care practices: the coronary artery disease in general practice (CADENCE) study","volume":"169","author":"Beltrame","year":"2009","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.ijcard.2021.07.018_bb0170","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.ijcard.2016.06.150","article-title":"Medical treatment of stable angina: a tailored therapeutic approach","volume":"220","author":"Manolis","year":"2016","journal-title":"Int. J. Cardiol."},{"issue":"2","key":"10.1016\/j.ijcard.2021.07.018_bb0175","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1038\/nrcardio.2017.131","article-title":"Expert consensus document: A \u2018diamond\u2019 approach to personalized treatment of angina","volume":"15","author":"Ferrari","year":"2018","journal-title":"Nat. Rev. Cardiol."},{"issue":"33","key":"10.1016\/j.ijcard.2021.07.018_bb0180","doi-asserted-by":"crossref","first-page":"3117","DOI":"10.1093\/eurheartj\/ehaa277","article-title":"Diversity is richness: why data reporting according to sex, age, and ethnicity matters","volume":"41","author":"L\u00fcscher","year":"2020","journal-title":"Eur. Heart J."},{"issue":"3","key":"10.1016\/j.ijcard.2021.07.018_bb0185","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1093\/ehjcvp\/pvw042","article-title":"Gender differences in the effects of cardiovascular drugs","volume":"3","author":"Tamargo","year":"2017","journal-title":"Eur Heart J. Cardiovasc. Pharmacother."},{"issue":"3","key":"10.1016\/j.ijcard.2021.07.018_bb0190","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.jacc.2006.05.044","article-title":"Antianginal efficacy of ranolazine when added to treatment with amlodipine: the ERICA (efficacy of ranolazine in chronic angina) trial. Randomized controlled trial","volume":"48","author":"Stone","year":"2006","journal-title":"J. Am. Coll. Cardiol."},{"issue":"5","key":"10.1016\/j.ijcard.2021.07.018_bb0195","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1097\/00000441-196605000-00008","article-title":"Double blind evaluation of orally administered iproveratril in patients with angina pectoris","volume":"251","author":"Neumann","year":"1966","journal-title":"Am J Med Sci"}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527321011633?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527321011633?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T20:53:16Z","timestamp":1759092796000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167527321011633"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":39,"alternative-id":["S0167527321011633"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2021.07.018","relation":{},"ISSN":["0167-5273"],"issn-type":[{"value":"0167-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Medical management of anginal symptoms in women with stable angina pectoris: A systematic review of randomised controlled trials","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2021.07.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}